FDA — authorised 16 October 2017
- Application: NDA207695
- Marketing authorisation holder: ANACOR PHARMS INC
- Indication: Labeling
- Status: approved
🇺🇸 Eucrisa in United States
FDA authorised Eucrisa on 16 October 2017
Marketing authorisation
Eucrisa in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in United States
Frequently asked questions
Is Eucrisa approved in United States?
Yes. FDA authorised it on 16 October 2017.
Who is the marketing authorisation holder for Eucrisa in United States?
ANACOR PHARMS INC holds the US marketing authorisation.